Dementia is often preceded by an earlier phase called mild cognitive impairment (MCI), where an individual is still able to live independently, but notices changes in at least one area […]

With an aging population and life expectancies on the rise, the number of people with dementia in the U.S. is projected to reach nearly 12 million in 20 years. However, […]

New Report – Lewy Body Dementia: State of the Science We are entering an era of unprecedented opportunity for understanding and treating Lewy body dementia (LBD). Our newest white paper, […]

The human genome is a complete set of a person’s DNA. Serving as a blueprint for all cells in the body, the genome contains about 20,000 genes. The first human […]

An LBD research advance by scientists at the National Institutes of Health (NIH) is making headlines. Using a procedure called a lumbar puncture (or spinal tap), researchers diagnosed two Lewy […]

In February of 2020 B.C. (before COVID-19), LBDA planned to host/attend 3 day-long meetings related to LBD research in June in Cleveland, OH. And then the pandemic hit. So, we […]

REM sleep behavior disorder (RBD) is a condition that causes a person to physically act out their dreams and is a common in Lewy body dementia (LBD). RBD is a […]

Lewy body pathology (presence of Lewy bodies in the brain)  is found in up to 50% of cases of late-onset Alzheimer’s disease, which can make it challenging for physicians to […]

Download this article as a PDF The importance of early treatment is supported by recent data suggesting that patients with LBD, might respond better to cholinesterase inhibitors than patients with […]

With all the recent news about failed clinical trials for disease-modifying treatments for Alzheimer’s disease, a little encouraging news is timely. ACADIA Pharmaceuticals announced an early end to one of […]